Documents
Resources
Learning Center
Upload
Plans & pricing Sign in
Sign Out

AXM Pharma, Inc. - Strategic SWOT Analysis Review

VIEWS: 79 PAGES: 19

AXM Pharma, Inc. (AXM), formerly Axiom Pharmaceuticals Inc, is a pharmaceutical and nutraceutical company. It undertakes production, marketing and distribution of various dosages and forms of medicinal treatment, herbal remedies, vitamins and adjunctive therapies. The company’s marketed products include Asarone, which acts as an anti-septic, anti-inflammatory, asthma reducing, including pediatric asthma, and coughs prevention medicine; Weifukang is used to relieve symptoms of dermatitis, seborrheica, eczema, and other skin diseases; Lifupeng (Rifampicin) is used for treatment of tuberculosis; LifeGate for increased energy and vitality. In addition, the company develops new drugs such as Whisper, Qiyao diabetes capsule, children's vitamins and vitamin supplements, Tong Yang and so on. Its products are marketed under brand names, namely, Soluleave, Elegance, LiveComf, Bodyward, Reheal and LifeGate. AXM is headquartered in California, the US.

More Info
									                             AXM Pharma, Inc. - Strategic SWOT Analysis Review
        Reference Code: GDPH61534SA                                                                                          Publication Date: AUG 2012

          20955 Pathfinder Road, Suite 100                   Phone             +1 909 8436338                   Revenue         NA
          Diamond Bar, CA                                    Fax               +1 909 8436350                   Net Profit      NA
          91765                                              Website           www.axmpharma.com                Employees       NA
                                                                                                                                Pharmaceuticals         &
          United States                                      Exchange                                           Industry
                                                                                                                                Healthcare

       Company Overview
       AXM Pharma, Inc. (AXM), formerly Axiom Pharmaceuticals Inc, is a pharmaceutical and nutraceutical company. It undertakes
       production, marketing and distribution of various dosages and forms of medicinal treatment, herbal remedies, vitamins and
       adjunctive therapies. The company’s marketed products include Asarone, which acts as an anti-septic, anti-inflammatory, asthma
       reducing, including pediatric asthma, and coughs prevention medicine; Weifukang is used to relieve symptoms of dermatitis,
       seborrheica, eczema, and other skin diseases; Lifupeng (Rifampicin) is used for treatment of tuberculosis; LifeGate for increased
       energy and vitality.
       Key Executives                                                             SWOT Analysis
                     Name                                Title                     AXM Pharma, Inc., SWOT Analysis
         Wang Wei Shi                      Chairman                                Strengths                            Weaknesses
         Elliot M. Maza                    Director
                                                                                   Broad Product Portfolio              Private Ownership
         Chaoying Li                       Director
                                                                                   Proprietary Manufacturing
         Baozhong Zhang                    Director
                                                                                   Facility
         Tracey O Neill                    Director
        Source: Company Website, Primary and Secondary Research,
        GlobalData                                                                 Opportunities                        Threats

                                                                                   Changing Demographics                Tightening of FDA’s Regulatory
        Key Competitors                                                                                                 Oversight
         MediciNova, Inc.                                                          New Product Developments
                                                                                                                        Industry Consolidation
         Lpath, Inc.
         Lixte Biotechnology Holdings, Inc.
                                                                                  Source: Company Website, Primary and Secondary Research, GlobalData
         Lescarden Inc.
        Ariad Pharmaceuticals, Inc.
        Source: Company Website, Primary and Secondary Research,
        GlobalData




AXM Pharma, Inc. - Strategic SWOT Analysis Review                                                                              Reference Code: GDPH61534SA
Source : www.globalcompanyintelligence.com                                                                                                                  Page 1
© GlobalData. This report is a licensed product and is not to be copied, reproduced, shared or resold in any form
       Table of Contents
       Table of Contents ............................................................................................................................................................................... 2
          List of Tables .................................................................................................................................................................................. 3
          List of Figures ................................................................................................................................................................................. 3
       Section 1 - About the Company.......................................................................................................................................................... 4
       AXM Pharma, Inc. - Key Facts ........................................................................................................................................................... 4
       AXM Pharma, Inc. - Key Employees .................................................................................................................................................. 5
       AXM Pharma, Inc. - Key Employee Biographies ................................................................................................................................ 6
       AXM Pharma, Inc. - Major Products and Services ............................................................................................................................. 7
       AXM Pharma, Inc. - History ................................................................................................................................................................ 8
       AXM Pharma, Inc. - Company Statement........................................................................................................................................... 9
       AXM Pharma, Inc. - Locations And Subsidiaries .............................................................................................................................. 10
          Head Office ................................................................................................................................................................................... 10
          Other Locations & Subsidiaries ..................................................................................................................................................... 10
       Section 2 – Company Analysis ......................................................................................................................................................... 11
       AXM Pharma, Inc. - Business Description ........................................................................................................................................ 11
       AXM Pharma, Inc. - SWOT Analysis ................................................................................................................................................ 12
          SWOT Analysis - Overview........................................................................................................................................................... 12
          AXM Pharma, Inc. - Strengths ...................................................................................................................................................... 12
             Strength - Broad Product Portfolio ............................................................................................................................................ 12
             Strength - Proprietary Manufacturing Facility ............................................................................................................................ 12
          AXM Pharma, Inc. - Weaknesses ................................................................................................................................................. 12
             Weakness - Private Ownership ................................................................................................................................................. 12
          AXM Pharma, Inc. - Opportunities ................................................................................................................................................ 12
             Opportunity - Changing Demographics ..................................................................................................................................... 12
             Opportunity - New Product Developments ................................................................................................................................ 13
             Opportunity - Focus on Emerging Markets ................................................................................................................................ 13
          AXM Pharma, Inc. - Threats ......................................................................................................................................................... 13
             Threat - Tightening of FDA’s Regulatory Oversight ...................................................................
								
To top